One shot to see clearly: cell therapy takes on corneal edema
⭐️ CURE ⭐️
Not yet recruiting
This phase 2 trial tests whether a single injection of EO2002, made from magnetic human corneal endothelial cells, can safely improve vision in people with corneal edema caused by endothelial dysfunction. Participants receive either a low or high dose of cells or a placebo inject…
Phase: PHASE2 • Sponsor: Emmecell • Aim: ⭐️ CURE ⭐️
Last updated Jul 28, 2026 16:00 UTC